Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 175


Postictal behavioural impairments are due to a severe prolonged hypoperfusion/hypoxia event that is COX-2 dependent.

Farrell JS, Gaxiola-Valdez I, Wolff MD, David LS, Dika HI, Geeraert BL, Rachel Wang X, Singh S, Spanswick SC, Dunn JF, Antle MC, Federico P, Teskey GC.

Elife. 2016 Nov 22;5. pii: e19352. doi: 10.7554/eLife.19352.


Reduction in cancer risk by selective and nonselective cyclooxygenase-2 (COX-2) inhibitors.

Harris RE, Beebe J, Alshafie GA.

J Exp Pharmacol. 2012 Aug 10;4:91-6. doi: 10.2147/JEP.S23826. Review.


Protein Markers Predict Survival in Glioma Patients.

Stetson LC, Dazard JE, Barnholtz-Sloan JS.

Mol Cell Proteomics. 2016 Jul;15(7):2356-65. doi: 10.1074/mcp.M116.060657.


Paulistine--The Functional Duality of a Wasp Venom Peptide Toxin.

Arcuri HA, Gomes PC, de Souza BM, Dias NB, Brigatte P, Stabeli RG, Palma MS.

Toxins (Basel). 2016 Feb 29;8(3). pii: E61. doi: 10.3390/toxins8030061.


Chronic stress in mice remodels lymph vasculature to promote tumour cell dissemination.

Le CP, Nowell CJ, Kim-Fuchs C, Botteri E, Hiller JG, Ismail H, Pimentel MA, Chai MG, Karnezis T, Rotmensz N, Renne G, Gandini S, Pouton CW, Ferrari D, Möller A, Stacker SA, Sloan EK.

Nat Commun. 2016 Mar 1;7:10634. doi: 10.1038/ncomms10634.


Molecular docking analysis of known flavonoids as duel COX-2 inhibitors in the context of cancer.

Dash R, Uddin MM, Hosen SM, Rahim ZB, Dinar AM, Kabir MS, Sultan RA, Islam A, Hossain MK.

Bioinformation. 2015 Dec 31;11(12):543-9. doi: 10.6026/97320630011543.


A Survival Association Study of 102 Polymorphisms Previously Associated with Survival Outcomes in Colorectal Cancer.

Savas S, Xu J, Werdyani S, Shestopaloff K, Dicks E, Green J, Parfrey P, Green R, Xu W.

Biomed Res Int. 2015;2015:968743. doi: 10.1155/2015/968743.


Direct Sequencing of Cyclooxygenase-2 (COX-2) Revealed an Intronic Variant rs201231411 in Iranian Patients with Pancreatic Cancer.

Mohamadkhani A, Akbari MR, Ghanbari R, Naderi E, Rezanejad-Asl P, Pourshams A.

Middle East J Dig Dis. 2015 Jan;7(1):14-8.


Prognostic importance of increased cyclooxygenase-2 levels in colorectal carcinomas: a 5-year single-institution study.

Okudur SS, Özer MT, Demirbaş S, Kalemoğlu M, Harlak A, Coşkun K, Eryılmaz M.

Eurasian J Med. 2008 Apr;40(1):6-9.


Therapeutic window for cyclooxygenase-2 related anti-inflammatory therapy after status epilepticus.

Jiang J, Yang MS, Quan Y, Gueorguieva P, Ganesh T, Dingledine R.

Neurobiol Dis. 2015 Apr;76:126-36. doi: 10.1016/j.nbd.2014.12.032.


Immunomodulatory effects of transforming growth factor-β in the liver.

Schon HT, Weiskirchen R.

Hepatobiliary Surg Nutr. 2014 Dec;3(6):386-406. doi: 10.3978/j.issn.2304-3881.2014.11.06. Review.


Implications of polyadenylation in health and disease.

Curinha A, Oliveira Braz S, Pereira-Castro I, Cruz A, Moreira A.

Nucleus. 2014;5(6):508-19. doi: 10.4161/nucl.36360. Review.


Prostacyclin regulates bone growth via the Epac/Rap1 pathway.

Hutchison MR, White PC.

Endocrinology. 2015 Feb;156(2):499-510. doi: 10.1210/en.2014-1348.


Cyclooxygenase-2 and the inflammogenesis of breast cancer.

Harris RE, Casto BC, Harris ZM.

World J Clin Oncol. 2014 Oct 10;5(4):677-92. doi: 10.5306/wjco.v5.i4.677. Review.


Post-translational regulation of COX2 activity by FYN in prostate cancer cells.

Alexanian A, Miller B, Chesnik M, Mirza S, Sorokin A.

Oncotarget. 2014 Jun 30;5(12):4232-43.


Targeted chiral analysis of bioactive arachidonic Acid metabolites using liquid-chromatography-mass spectrometry.

Mesaros C, Blair IA.

Metabolites. 2012 Apr 20;2(2):337-65. doi: 10.3390/metabo2020337.


Role of cyclooxygenase isoforms in the altered excitatory motor pathways of human colon with diverticular disease.

Fornai M, Colucci R, Antonioli L, Ippolito C, Segnani C, Buccianti P, Marioni A, Chiarugi M, Villanacci V, Bassotti G, Blandizzi C, Bernardini N.

Br J Pharmacol. 2014 Aug;171(15):3728-40. doi: 10.1111/bph.12733.


Network analysis of inflammatory genes and their transcriptional regulators in coronary artery disease.

Nair J, Ghatge M, Kakkar VV, Shanker J.

PLoS One. 2014 Apr 15;9(4):e94328. doi: 10.1371/journal.pone.0094328.

Items per page

Supplemental Content

Support Center